advertisement
11.16 Vehicles, delivery systems, pharmacokinetics, formulation (65)
Showing records 1 to 25
Search within classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation94856 Risk Factors for Ocular Surface Disease in Tunisian Users of Preserved Antiglaucomatous Eye Drops
Lajmi H
Journal of current ophthalmology 2021; 33: 128-135
94838 Relationship between OSDI score and biomicroscopic ocular surface damages in glaucomatous patients treated with preserved antiglaucomatous eye drops
Lajmi H
Journal Français d'Ophtalmologie 2021; 44: 1326-1331
94955 Surface Engineering of FLT4-Targeted Nanocarriers Enhances Cell-Softening Glaucoma Therapy
Vincent MP
ACS applied materials & interfaces 2021; 13: 32823-32836
94547 European real-world data about the use of a new delivery system containing a preservative-free multi-dose glaucoma treatment
Denis P
European Journal of Ophthalmology 2021; 31: 1056-1063
94980 Nano-in-Nano Dendrimer Gel Particles for Efficient Topical Delivery of Antiglaucoma Drugs into the Eye
Wang J
Chemical engineering journal (Lausanne, Switzerland : 1996) 2021; 425:
94766 A Review on Newer Ocular Drug Delivery Systems with an Emphasis on Glaucoma
Peter M
Advanced pharmaceutical bulletin 2021; 11: 399-413
94930 Gamma sterilization and in vivo evaluation of cationic nanostructured lipid carriers as potential ocular delivery systems for antiglaucoma drugs
Youshia J
European Journal of Pharmaceutical Sciences 2021; 163: 105887
94845 Efficacy and Safety of Preservative-free Latanoprost Eyedrops Compared with Preserved Prostaglandin Analogues in Patients with Open-angle Glaucoma
Seong HJ
Korean Journal of Ophthalmology 2021; 35: 235-241
94855 Distribution of Gold Nanoparticles in the Anterior Chamber of the Eye after Intracameral Injection for Glaucoma Therapy
Sonntag T
Pharmaceutics 2021; 13:
94821 Phase Transition Microemulsion of Brimonidine Tartrate for Glaucoma Therapy: Preparation, Characterization and Pharmacodynamic Study
Gautam N
Current Eye Research 2021; 0: 1-9
94436 Cyclodextrin-based formulation of carbonic anhydrase inhibitors for ocular delivery - A review
Jansook P
International Journal of Pharmaceutics 2021; 606: 120955
94413 Comparison of Topical Instillation From Single-dose and Multidose Eye Drop Containers in Glaucoma: A Multicenter Randomized Cross-sectional Trial
Aptel F
Journal of Glaucoma 2021; 30: 718-724
94436 Cyclodextrin-based formulation of carbonic anhydrase inhibitors for ocular delivery - A review
Hnin HM
International Journal of Pharmaceutics 2021; 606: 120955
94845 Efficacy and Safety of Preservative-free Latanoprost Eyedrops Compared with Preserved Prostaglandin Analogues in Patients with Open-angle Glaucoma
Lee K
Korean Journal of Ophthalmology 2021; 35: 235-241
94413 Comparison of Topical Instillation From Single-dose and Multidose Eye Drop Containers in Glaucoma: A Multicenter Randomized Cross-sectional Trial
Villemont AS
Journal of Glaucoma 2021; 30: 718-724
94856 Risk Factors for Ocular Surface Disease in Tunisian Users of Preserved Antiglaucomatous Eye Drops
Hmaied W
Journal of current ophthalmology 2021; 33: 128-135
94547 European real-world data about the use of a new delivery system containing a preservative-free multi-dose glaucoma treatment
Duch S
European Journal of Ophthalmology 2021; 31: 1056-1063
94766 A Review on Newer Ocular Drug Delivery Systems with an Emphasis on Glaucoma
Panonnummal R
Advanced pharmaceutical bulletin 2021; 11: 399-413
94930 Gamma sterilization and in vivo evaluation of cationic nanostructured lipid carriers as potential ocular delivery systems for antiglaucoma drugs
Kamel AO
European Journal of Pharmaceutical Sciences 2021; 163: 105887
94838 Relationship between OSDI score and biomicroscopic ocular surface damages in glaucomatous patients treated with preserved antiglaucomatous eye drops
Chelly Z
Journal Français d'Ophtalmologie 2021; 44: 1326-1331
94955 Surface Engineering of FLT4-Targeted Nanocarriers Enhances Cell-Softening Glaucoma Therapy
Stack T
ACS applied materials & interfaces 2021; 13: 32823-32836
94980 Nano-in-Nano Dendrimer Gel Particles for Efficient Topical Delivery of Antiglaucoma Drugs into the Eye
Li B
Chemical engineering journal (Lausanne, Switzerland : 1996) 2021; 425:
94855 Distribution of Gold Nanoparticles in the Anterior Chamber of the Eye after Intracameral Injection for Glaucoma Therapy
Froemel F
Pharmaceutics 2021; 13:
94821 Phase Transition Microemulsion of Brimonidine Tartrate for Glaucoma Therapy: Preparation, Characterization and Pharmacodynamic Study
Kesavan K
Current Eye Research 2021; 0: 1-9
94436 Cyclodextrin-based formulation of carbonic anhydrase inhibitors for ocular delivery - A review
Loftsson T
International Journal of Pharmaceutics 2021; 606: 120955
